RESEARCH TRIANGLE PARK, N.C. - Fennec Pharmaceuticals (NASDAQ:FENC) Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that ...

(NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that their partner, Norgine Pharmaceuticals Ltd., has launched PEDMARQSI ...

When European pharma company Norgine saw an unmet need in how patients were seeking information on one of its brands, they decided to implement a chatbot to help people find the answers they needed.

Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the ...

X4 Pharmaceuticals (XFOR) and Norgine announced that they have entered into an exclusive licensing and supply agreement under which Norgine will commercialize mavorixafor in Europe, Australia ...

13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, and Norgine, a leading European specialist ...

Now select the ‘Manage’ option appearing in the top ribbon under the ‘Picture Tools’ Select the ‘Slide Show’ option to begin the photos slideshow. As soon as you click the ‘Slide ...